KJIM :: Korean Journal of Internal Medicine

Hydroxychloroquine: Pharmacokinetics and Toxicity

Philippe Brouqui, Eric Chabrière, Didier Raoult, Md Saquib Hasnain

Journal of Clinical Pharmacy and Therapeutics.2024; 2024: 1. CrossRef

An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: A comprehensive review

International Journal of Biological Macromolecules.2024; 267: 131324. CrossRef

The Safety and Efficacy of the Protease Inhibitors Lopinavir/Ritonavir as Monotherapy or Combined with Interferon in COVID-19 Patients

Mahmoud Kandeel, Mohamed A. Morsy, Hany M. Abd El-Lateef, Mohamed Marzok, Hossam S. El-Beltagi, Khalid M. Al Khodair, Ibrahim Albokhadaim, Katharigatta N. Venugopala

Outpatient medications associated with protection from COVID-19 hospitalization

Harpal Singh Sandhu, Joshua Lambert, Zach Steckler, Lee Park, Arnold Stromberg, Julio Ramirez, Chi-fu Jeffrey Yang, Lakshmi Kannan

In silico Study of Antiviral Activity of Polyphenol Compounds from Ocimum basilicum by Molecular Docking, ADMET, and Drug-Likeness Analysis

Dikdik Kurnia, Salsabila Aqila Putri, Sefren Geiner Tumilaar, Achmad Zainuddin, Hendra Dian Adhita Dharsono, Meiny Faudah Amin

Advances and Applications in Bioinformatics and Chemistry.2023; Volume 16: 37. CrossRef

Risk Factors for the Prescription of Ineffective Antiviral Candidates for COVID-19 During the Early Pandemic Period in Korea

Eunyoung Lee, Seungyeon Kim, Sun Young Lee, Joo Jeong, Jihwan Bang, Juhwan Oh, Sang Do Shin, Nam Joong Kim, Pyoeng Gyun Choe, Myoung-don Oh

Journal of Korean Medical Science.2023;[Epub] CrossRef

Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection

Efficacy of lopinavir–ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis

Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, Zachary Silver, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Chi Yi Wong, Qi Kang Zuo, Elizabeth Lapshina, Madeline Mellett

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lu, Ming Wang, Lin Zhu, Junjian Hu, Tingting Liu, Ke Ma, Meifang Han, Xiaoping Luo

Signal Transduction and Targeted Therapy.2022;[Epub] CrossRef

Experimental Models of SARS-CoV-2 Infection: Possible Platforms to Study COVID-19 Pathogenesis and Potential Treatments

Sareh Pandamooz, Benjamin Jurek, Carl-Philipp Meinung, Zahra Baharvand, Alireza Sahebi Shahem-abadi, Silke Haerteis, Jaleel A. Miyan, James Downing, Mehdi Dianatpour, Afshin Borhani-Haghighi, Mohammad Saied Salehi

Annual Review of Pharmacology and Toxicology.2022; 62(1): 25. CrossRef

Drug safety of frequently used drugs and substances for self-medication in COVID-19

Daniela Baracaldo-Santamaría, Santiago Pabón-Londoño, Luis Carlos Rojas-Rodriguez

Therapeutic Advances in Drug Safety.2022; 13: 204209862210941. CrossRef

A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease

Alessandra S. Rieder, Bruna F. Deniz, Carlos Alexandre Netto, Angela T.S. Wyse

Neurotoxicity Research.2022; 40(5): 1553. CrossRef

Immune-related adverse events of biological immunotherapies used in COVID-19

Daniela Baracaldo-Santamaría, Giovanna María Barros-Arias, Felipe Hernández-Guerrero, Alejandra De-La-Torre, Carlos-Alberto Calderon-Ospina

Celastrol: A lead compound that inhibits SARS‐CoV‐2 replication, the activity of viral and human cysteine proteases, and virus‐induced IL‐6 secretion

Carlos A. Fuzo, Ronaldo B. Martins, Thais F. C. Fraga‐Silva, Martin K. Amstalden, Thais Canassa De Leo, Juliano P. Souza, Thais M. Lima, Lucia H. Faccioli, Débora Noma Okamoto, Maria Aparecida Juliano, Suzelei C. França, Luiz Juliano, Vania L. D. Bonato,

Drug Development Research.2022; 83(7): 1623. CrossRef

Recent review of COVID-19 management: diagnosis, treatment and vaccination

Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Aayushi B. Patel, Nikita Sharma, Zhe-Sheng Chen

Pharmacological Reports.2022; 74(6): 1120. CrossRef

A Recent Update on the Clinical Trials and Effectiveness of Drugs Used in COVID-19, MERS and SARS Coronaviruses

Seyed Sajad Hosseini Balef, Zohreh Karimi, Aala Azari, Seyed Sadeq Sadraei, Parisa Hasanjani, Yasaman Sadeghi, Samin Ahmadi, Fateme Qorbannejad, Ali Farmoudeh, Hamid Irannejad

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study

Min Joo Choi, Minsun Kang, So Youn Shin, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, Jaehun Jung, Joon Young Song

International Journal of Infectious Diseases.2021; 102: 275. CrossRef

Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment

Paola Magro, Isabella Zanella, Marta Pescarolo, Francesco Castelli, Eugenia Quiros-Roldan

Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective

Opeyemi S Soremekun, Kehinde F Omolabi, Adeniyi T Adewumi, Mahmoud ES Soliman

Susceptibility to COVID‐19 in Patients Treated With Antimalarials: A Population‐Based Study in Emilia‐Romagna, Northern Italy

Carlo Salvarani, Pamela Mancuso, Federica Gradellini, Nilla Viani, Paolo Pandolfi, Massimo Reta, Giuliano Carrozzi, Gilda Sandri, Gianluigi Bajocchi, Elena Galli, Francesco Muratore, Luigi Boiardi, Nicolò Pipitone, Giulia Cassone, Stefania Croci, Anna Mar

Arthritis & Rheumatology.2021; 73(1): 48. CrossRef

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study

Krishnaprasad Baby, Swastika Maity, Chetan H. Mehta, Akhil Suresh, Usha Y. Nayak, Yogendra Nayak

European Journal of Pharmacology.2021; 896: 173922. CrossRef

Computational drug screening against the SARS-CoV-2 Saudi Arabia isolates through a multiple-sequence alignment approach

Pooi Ling Mok, Avin Ee-Hwan Koh, Aisha Farhana, Abdullah Alsrhani, Mohammad Khursheed Alam, Subbiah Suresh Kumar

Saudi Journal of Biological Sciences.2021; 28(4): 2502. CrossRef

Therapeutic Strategies in the Management of COVID-19

Frontiers in Molecular Biosciences.2021;[Epub] CrossRef

Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications

Tessa M. Firestone, Opeoluwa O. Oyewole, St Patrick Reid, Caroline L. Ng

ACS Pharmacology & Translational Science.2021; 4(2): 613. CrossRef

Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials

Tejas K. Patel, Parvati B. Patel, Manish Barvaliya, Manoj Kumar Saurabh, Hira Lal Bhalla, Prem Parkash Khosla

Journal of Infection and Public Health.2021; 14(6): 740. CrossRef

Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19

Gustavo José da Silva Pereira, Anderson Henrique França Figueredo Leão, Adolfo Garcia Erustes, Ingrid Beatriz de Melo Morais, Talita Aparecida de Moraes Vrechi, Lucas dos Santos Zamarioli, Cássia Arruda Souza Pereira, Laís de Oliveira Marchioro, Letícia P

International Journal of Molecular Sciences.2021; 22(8): 4067. CrossRef

The Anti-Viral and Anti-Inflammatory Properties of Edible Bird’s Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application

Kien Hui Chua, Isa Naina Mohamed, Mohd Heikal Mohd Yunus, Norefrina Shafinaz Md Nor, Khidhir Kamil, Azizah Ugusman, Jaya Kumar

Clinical Presentation, Management, and Outcomes of Patients with COVID-19 Disease: A Report from a Large Tertiary Hospital in Iran

Bahram Dehghan, Ahmad Abeshtan, Abdullah Sarami, Saied Saeidimehr, Elham Maraghi, Fakher Rahim

Jundishapur Journal of Health Sciences.2021;[Epub] CrossRef

A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery

Yun-Yun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing, Fuxiang Zheng, Mang Shi, Ji-An Pan, Xiaoxue Peng, Deyin Guo

Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside

Yusuf Oloruntoyin Ayipo, Sani Najib Yahaya, Waleed A. Alananzeh, Halimah Funmilayo Babamale, Mohd Nizam Mordi

Infection, Genetics and Evolution.2021; 93: 104944. CrossRef

Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review

Future Journal of Pharmaceutical Sciences.2021;[Epub] CrossRef

COVID‐19 in heart transplant recipients during February–August 2020: A systematic review

Carlos Diaz‐Arocutipa, Darla Carvallo‐Castañeda, Odalis Luis‐Ybañez, Marcos Pariona, Mercedes Rivas‐Lasarte, Jesús Álvarez‐García

Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions

COVID-19: potential therapeutics for pediatric patients

Nour K. Younis, Rana O. Zareef, Ghina Fakhri, Fadi Bitar, Ali H. Eid, Mariam Arabi

Pharmacological Reports.2021; 73(6): 1520. CrossRef

Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics

Csilla Ambrus, Éva Bakos, Balázs Sarkadi, Csilla Özvegy-Laczka, Ágnes Telbisz

Recent Advances on Drugs and Vaccines for COVID-19

INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2021; 58: 004695802110556. CrossRef

COVID-19 Therapeutic Options Under Investigation

Malak Kaddoura, Malak AlIbrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, Salame Haddad, Ali Eid, Hassan Zaraket

It is time to drop hydroxychloroquine from our COVID-19 armamentarium

Overview of management of children with COVID-19

Clinical and Experimental Pediatrics.2020; 63(9): 345. CrossRef

Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19

Ahmed Rakib, Arkajyoti Paul, Md. Nazim Uddin Chy, Saad Ahmed Sami, Sumit Kumar Baral, Mohuya Majumder, Abu Montakim Tareq, Mohammad Nurul Amin, Asif Shahriar, Md. Zia Uddin, Mycal Dutta, Trina Ekawati Tallei, Talha Bin Emran, Jesus Simal-Gandara

Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

Gerwyn Morris, Eugene Athan, Ken Walder, Chiara C. Bortolasci, Adrienne O'Neil, Wolf Marx, Michael Berk, André F. Carvalho, Michael Maes, Basant K. Puri

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks

Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk, Hans-Peter Deigner

International Journal of Molecular Sciences.2020; 21(14): 4953. CrossRef

A 21st Century Evil: Immunopathology and New Therapies of COVID-19

Taylon Felipe Silva, Fernanda Tomiotto-Pellissier, Raquel Arruda Sanfelice, Manoela Daiele Gonçalves, Bruna Taciane da Silva Bortoleti, Mariana Barbosa Detoni, Ana Carolina Jacob Rodrigues, Amanda Cristina Machado Carloto, Virgínia Márcia Concato, Elaine

Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections

Keneth Iceland Kasozi, Gniewko Niedbała, Mohammed Alqarni, Gerald Zirintunda, Fred Ssempijja, Simon Peter Musinguzi, Ibe Michael Usman, Kevin Matama, Helal F. Hetta, Ngala Elvis Mbiydzenyuy, Gaber El-Saber Batiha, Amany Magdy Beshbishy, Susan Christina We

Vaccines and Treatment of Coronavirus Disease 2019

The Korean Journal of Medicine.2020; 95(6): 364. CrossRef